{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T12:24:58Z","timestamp":1792671898621,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.ejso.2019.02.031","type":"journal-article","created":{"date-parts":[[2019,2,25]],"date-time":"2019-02-25T03:03:13Z","timestamp":1551063793000},"page":"75-81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["A comparison of outcomes following total and selective peritonectomy performed at the time of interval cytoreductive surgery for advanced serous epithelial ovarian, fallopian tube and primary peritoneal cancer \u2013 A study by INDEPSO"],"prefix":"10.1016","volume":"47","author":[{"given":"Snita","family":"Sinukumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Firoz","family":"Rajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanket","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dileep","family":"Damodaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shabber","family":"Zaveri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praveen","family":"Kammar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditi","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.ejso.2019.02.031_bib1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s40944-017-0148-7","article-title":"Cytoreductive surgery and HIPEC in the first-line and interval time points of advanced epithelial ovarian cancer","volume":"15","author":"Kusamura","year":"2017","journal-title":"Indian J Gynecol Oncol"},{"key":"10.1016\/j.ejso.2019.02.031_bib2","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.ygyno.2006.06.025","article-title":"Platinum-based neoadjuvant chemotherapy and interval surgical cytoreduction for advanced ovarian cancer: a meta-analysis","volume":"103","author":"Bristow","year":"2006","journal-title":"Gynecol Oncol"},{"issue":"15","key":"10.1016\/j.ejso.2019.02.031_bib3","article-title":"Randomized trial of hypterthermic intraperitoneal chemotherapy (HIPEC) in women with primary advanced peritoneal, ovarian and tubal cancer","volume":"35","author":"Lim","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"issue":"14","key":"10.1016\/j.ejso.2019.02.031_bib4","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1016\/j.ejca.2006.03.025","article-title":"Impact of pattern of recurrence on clinical outcome of ovarian cancer patients: clinical considerations","volume":"42","author":"Ferrandina","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejso.2019.02.031_bib5","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1245\/s10434-012-2237-2","article-title":"Cytoreductive surgery with selective versus complete parietal peritonectomy followed by hyperthermic intraperitoneal chemotherapy in patients with diffuse malignant peritoneal mesothelioma: a controlled study","volume":"19","author":"Baratti","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2019.02.031_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijgo.2013.10.001","article-title":"Staging classification for cancer of the ovary, fallopian tube, and peritoneum","volume":"124","author":"Prat","year":"2014","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ejso.2019.02.031_bib7","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/978-1-4613-1247-5_23","article-title":"Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis","volume":"82","author":"Jacquet","year":"1996","journal-title":"Cancer Treat Res"},{"key":"10.1016\/j.ejso.2019.02.031_bib8","first-page":"185092","article-title":"Pharmacokinetic study of perioperative intravenous Ifosfamide","volume":"2011","author":"Van der Speeten","year":"2011","journal-title":"Int J Surg Oncol"},{"key":"10.1016\/j.ejso.2019.02.031_bib9","series-title":"Management of peritoneal metastases- cytoreductive surgery, HIPEC and beyond","first-page":"389","article-title":"Early postoperative intraperitoneal chemotherapy: current role and future perspectives","author":"Douchy","year":"2018"},{"issue":"22","key":"10.1016\/j.ejso.2019.02.031_bib10","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1200\/JCO.2014.60.5212","article-title":"Chemotherapy response score: development and validation of a system to quantify histopathologic response to neo- adjuvant chemotherapy in tubo-ovarian high-grade serous carcinoma","volume":"33","author":"B\u00f6hm","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"issue":"8","key":"10.1016\/j.ejso.2019.02.031_bib11","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/modpathol.2015.77","article-title":"Data set for reporting of ovary, fallopian tube and primary peritoneal carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR)","volume":"28","author":"McCluggage","year":"2015","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.ejso.2019.02.031_bib12","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s13193-016-0501-9","article-title":"The role of cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in ovarian cancer: a review","volume":"7","author":"Bhatt","year":"2016","journal-title":"Indian J Surg Oncol"},{"key":"10.1016\/j.ejso.2019.02.031_bib13","doi-asserted-by":"crossref","first-page":"4073","DOI":"10.1200\/JCO.2011.35.9935","article-title":"Is the easier way ever the better way?","volume":"29","author":"Chi","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2019.02.031_bib14","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1470-2045(17)30777-5","article-title":"Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials","volume":"19","year":"2018","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2019.02.031_bib15","first-page":"277","article-title":"Neoadjuvant chemo radiation therapy and pathological complete response in rectal cancer","volume":"3","author":"Ferrari","year":"2015","journal-title":"Gastroenterol Rep"},{"key":"10.1016\/j.ejso.2019.02.031_bib16","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ygyno.2011.08.014","article-title":"An analysis of patients with bulky advanced stage ovarian, tubal, and peritoneal carcinoma treated with primary debulking surgery (PDS) during an identical time period as the randomized EORTC-NCIC trial of PDS vs neoadjuvant chemotherapy (NACT)","volume":"124","author":"Chi","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2019.02.031_bib17","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ygyno.2012.11.007","article-title":"Is perioperative visual estimation of intra-abdominal tumor spread reliable in ovarian cancer surgery after neoadjuvant chemotherapy?","volume":"128","author":"Hynninen","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2019.02.031_bib18","article-title":"Neoadjuvant chemotherapy versus primary debulking surgery in advanced epithelial ovarian cancer: a meta-analysis of perioperative outcome","volume":"vol. 12","author":"Yang","year":"2017"},{"key":"10.1016\/j.ejso.2019.02.031_bib19","doi-asserted-by":"crossref","first-page":"4946","DOI":"10.1200\/JCO.2007.12.2317","volume":"25","author":"Chi","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2019.02.031_bib20","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1159\/000313823","article-title":"Residual cancer stem cells after interval cytoreductive surgery following neoadjuvant chemotherapy could result in poor treatment outcomes for ovarian cancer","volume":"33","author":"Lim","year":"2010","journal-title":"Onkologie"},{"key":"10.1016\/j.ejso.2019.02.031_bib21","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/stem.200011","article-title":"ABC transporters as phenotypic markers and functional regulators of stem cells","volume":"20","author":"Bunting","year":"2002","journal-title":"Stem Cell"},{"issue":"4","key":"10.1016\/j.ejso.2019.02.031_bib22","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.7314\/APJCP.2016.17.4.2271","article-title":"5-Aminolevulinic acid fluorescence in detection of peritoneal metastases","volume":"17","author":"Yonemura","year":"2016","journal-title":"Asian Pac J Cancer Prev APJCP"},{"key":"10.1016\/j.ejso.2019.02.031_bib23","doi-asserted-by":"crossref","DOI":"10.1245\/s10434-017-6099-5","article-title":"Total mesenteric peritonectomy for peritoneal metastases (with video)","author":"Cazauran","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2019.02.031_bib24","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ygyno.2011.09.011","article-title":"Patterns of first recurrence following adjuvant intraperitoneal chemotherapy for stage IIIC ovarian cancer","volume":"124","author":"Tanner","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2019.02.031_bib25","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1245\/s10434-014-4083-x","article-title":"Outcome of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy on patients with diaphragmatic involvement","volume":"22","author":"Franssen","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2019.02.031_bib26","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1245\/s10434-016-5686-1","article-title":"Cytoreduction (peritonectomy procedures) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in advanced ovarian cancer: retrospective Italian multicenter observational study of 511 cases","volume":"24","author":"Di Giorgio","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2019.02.031_bib27","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.ejso.2013.09.030","article-title":"Peritoneal carcinomatosis treated with cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for advanced ovarian carcinoma: a French multicentre retrospective cohort study of 566 patients","volume":"39","author":"Bakrin","year":"2013","journal-title":"Eur J Surg Oncol"},{"issue":"15","key":"10.1016\/j.ejso.2019.02.031_bib28","article-title":"A\u00a0phase 3 trial of hyperthermic intraperitoneal chemotherapy (HIPEC) for ovarian cancer","volume":"35","author":"Van Driel","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2019.02.031_bib29","first-page":"16","article-title":"Ovarian cancers: genetic abnormalities, tumor heterogeneity and progression, clonal evolution and cancer stem cells","volume":"5","author":"Testa","year":"2018","journal-title":"Medicines (Basel)"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S074879831930304X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S074879831930304X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T16:06:27Z","timestamp":1755273987000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S074879831930304X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S074879831930304X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2019.02.031","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A comparison of outcomes following total and selective peritonectomy performed at the time of interval cytoreductive surgery for advanced serous epithelial ovarian, fallopian tube and primary peritoneal cancer \u2013 A study by INDEPSO","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2019.02.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.","name":"copyright","label":"Copyright"}]}}